Skip to content
sellWeak10b5-1 plan

Melnikov Dmitry sold $550k of SEMR

director, owner at SEMrush Holdings, Inc.. 45,187 shares at an average of $12.17, traded Dec 24, 2024, filed Dec 27, 2024.

Warning score
14
Value
$550k
45,187 shares
Holdings after
8,822,938
-1% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001628280-24-052519, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Dec 24, 2024SOpen-market sale
Class A Common Stockindirect: The Melnikov Family GRAT Remainder Trust10b5-1
-10,361$12.33$128k8,857,764Dec 27, 2024
Dec 26, 2024SOpen-market sale
Class A Common Stockindirect: The Melnikov Family GRAT Remainder Trust10b5-1
-16,467$12.26$202k8,841,297Dec 27, 2024
Dec 27, 2024SOpen-market sale
Class A Common Stockindirect: The Melnikov Family GRAT Remainder Trust10b5-1
-18,359$12.00$220k8,822,938Dec 27, 2024

Related signals

Other insiders at SEMrush Holdings, Inc. and this insider’s other filings.

ScoreSideCompanyInsiderValueSharesFiled
11Weaksell10b5-1SEMR
SEMrush Holdings, Inc.
Melnikov Dmitry
director, owner
$409k34,629
18Weaksell10b5-1SEMR
SEMrush Holdings, Inc.
Melnikov Dmitry
director, owner
$889k72,476
20Weaksell10b5-1SEMR
SEMrush Holdings, Inc.
Melnikov Dmitry
director, owner
$1.5M119,700
28Weaksell 210b5-1SEMR
SEMrush Holdings, Inc.
Melnikov Dmitry
director, owner
$1.1M81,016
22Weaksell 210b5-1SEMR
SEMrush Holdings, Inc.
Melnikov Dmitry
director, owner
$587k42,342
38Weaksell 210b5-1SEMR
SEMrush Holdings, Inc.
Levin Eugenie
President
$988k72,000
15WeaksellSEMR
SEMrush Holdings, Inc.
Mason David W
General Counsel
$21k1,589
29WeaksellSEMR
SEMrush Holdings, Inc.
Mulroy Brian
Chief Financial Officer
$55k4,207

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.